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Developing Gene Therapy 
Researchers at the University of Pennsylvania 
School of Veterinary Medicine are te:mng methods 
for transferring normal genes into the cells of 
animals affected by enzyme deficiencies that cause 
severe and often fatal disorders in borh humans and 
animals. 
The en.cyme deficiency diseases, called 
mucopolysaccharidoses, or MPS diseases, are 
progressive degenerative disorders ol children and 
young animals usually characterized by .. evere bone 
abnormalities, heart defects, impaired vis1on. mental 
retardation. and premature death. The diseases are 
caused by deficiencies in enzymes whose normal 
function is to break down specific molecules m the 
ceU. 
The curren1 research at Penn has focused on 
developing and testing vectors. or carriers, that can 
�uccessfully deliver healthy enzyme genes into MPS 
affected cells. 
In a presentation in Washington, D.C. at the 
American Veterinary Medical Association 
conference on genetic engineering, Dr. John Wolfe 
of the Gene Therapy Research Group at Penn said 
the group had developed a vector that is an effective 
�-:arricr for one of the healthy genes. When 
transferred, the gene corrected the abnormalities of 
the diseased cell. 
''The preliminary tests indicate that retroviral 
vector gene transfer may be a feasible approach for 
treating MPS diseases," Wolfe said. 
Rctro' iral vectors acr as a delivery y�tcm for 
placing the normal gene into the diseased cell. 
Rctroviru�e� have proven to be good �;a11 ie1�. \Volfe 
said, becau'c the� are capable of in�cs 11ng the gene 
into the DNA of the hosL cell, and they arc rclauvely 
.simple viruo;es that have been exterui\ely modified so 
th�y do not harm the cells in whlcb they are placed. 
The initial testing, which has taken place within the 
last si:\ to eight months, has been performed in tissue 
culture using diseased cells from animals affected 
Equine Symposium 
for Students 
Student!> organized an all-day equine !>ymposium. 
consisting of hands·on demonstratiOn!> and lectures 
on November 19. The topic$ offered in the 
presentations and laboratories were: familiarization 
with the Y AG Laser; cytology; cardiology and useful 
equipment; semen handling and processing: embryo 
tran:>fcr; marc reproductive tract: oblique 
radiographs for common equine problems; neonatal 
mten!>ive care; lameness diagnosis; principles of 
internal fixation: to" power laser and acupuncture: 
diagno!.uc ultrasound of the equine limb; colic; and 
enc.lo copy. In the afternoon a lecture on the 
prcpurcha!>C exam and its legal implicauons was 
presemed. The following clinicians and tesJdcnts 
participated and volunteered their t1mc for event: Dr. 
Eric Tulleners. Dr. Ellen Ziemer, Dr. Johanna 
Reimer, Dr. Charles Love, Dr. Patricia Sertich, Dr. 
Martin Burton, Dr. Curtis Scbelling, Dr. Wendy 
Vaala, Dr. Dan Dreyfuss, Dr. James Orsini, Dr. 
Uenson Martin, Dr. Virginia Reef, Dr. JaneL 
Johnston. Or. Alan Ruggles, Dr. Yvc'> Rossier. Dr. 
Lm 1-.lcm, Dr. William \ioyer, and Dr. James 
Wilson. 
lO Bell\tet.her 
with an MPS disorder, Wolfe said. The newly­
developed vectors have been able to transfer the gene 
to MPS cells. where the transferred gene has 
corrected the defect in the diseased cells. 
The work at Penn has been performed in 
collaboration with the Memonal Sloan-Kettering 
Cancer Center and the Mt. Sinai School of Medicine 
in New York. 
The next step, Wolfe said, will be to begin testing 
to determine if the vectors can be transferred to and 
function in diseased animals to actually alter the 
course of the disease. 
Although �1PS disorders are quite rare in the 
general population, they often occur with high 
frequency w1thin families that carry the defective 
gene. Beside� the .MPS disorders. there are several 
thousand other fonns of genetic d1sease. Effective 
treatments are available now for only a few of those 
disorders. Mauy researchers believe lhe new field of 
gene therapy research offers an approach to the 
treatment of previously incurable geneuc disorders of 
animals and humans. 
ln gene therapy, Wolfe explained. cells are 
removed from the patient and placed into tiss\IC 
culture; the normal gene is inserted; and the 
t--orreeted cells arc returned to the patient. 
''It IS replacing something that is m1ssing from the 
ceU," Wolfe �aid. "ln effect, it is similar to giving 
insulin for the treatment of diabetes. However, 
unli�e insulin, the effect of the gene therapy 
treatment would be permanent." 
Researchers face several challenges in achieving 
.. u�'\:�,.,rul 11enc therapy The:- gc:nt In' olvecl in the 
di'oease muM be tdentified- "!ll(:h ha:. not ye1 been 
accomplished for many genetic diseases: the gene 
must be cloned. or duplicated; an effective vector, or 
delivery syc;tem, must be constructed to transfer the 
ne" gene into the diseased ceUs; the vector must be 
capable of transferring the gene to the correct target 
cell; the transferred gene must function correctly 
Dog �ith MPS Vll 
once it reaches the diseased cell: and, linally. the 
transferred gene must be able to cure or substant1all) 
aller the course of the diseru;e for gene therapy to be 
considered successful. 
The MPS dise�es are good subjects for gene 
therapy research because the def�tive genes have 
been identifietl and can be duplicated. And, Wolfe 
said. since the MPS diseases that occur u'l am als are 
very similar to those that occur in humans. what ts 
learned from studying the MPS affected animals 
should be highly applicable to treating the diseases in 
humans . 
· This is a good example of reciprocal benet;: tn 
hurnan and ammal medicine," \\'olfe satd. MPS "'as 
first discovered in humans, and that led to its 
discm.:cry in animals. 
• 'The information and benefits no" back and 
forth between animal and human medicine.'' 
Phyllis Holtzman 
SCAVMA Activities 
The second annual Student Teadung r\\\ards 
Dinner will be held on Sunday, Apnl 2, 1989, 6:00 
pm at the Hotel DuPont in Wilmington, DE- Tickets 
will be $17.00each for students and $30 OOeach for 
faculty. Look for Lhe invitations in the mail. Last 
year 200 students and 150 faculty, staff and alumni 
attended 1 he dinner at Longwood Gardens. AU 
enjoyed the feast and ceremonies and are looking 
forward to this year's everu. 
SCA \ MA 's annual December auction exceeded a1J 
expectations. Support was tremendous. $9,000 were 
raised. The funds will be used b� the faculty/ 
SCA V\1A fund to provide money tor the student 
emergency loan fund. Part of the proceeds will help 
defray the cost of student tickets to the Dinner 
Dance. 
Bigger and better than ever-SCA VMA 's latest 
fund raising effort is a 'Boutique' in the student 
lounge. It offers a great selection of sweatshirts, 
sweatpants, T·sbirts, jogging short!>, mugs and can 
coolers-available in a variety of colors and graphic 
d�igns. AJso beginning in January, merchandise will 
be available at New Bohon Center in the cafeteria on 
rridays. 
This year's SCA VMA student sympo.s1um will be 
held at North Carolina State University, in Raleigh­
Durham. Approximately 80 students from Penn will 
participate in the event. Funds raised by SCA VMA 
throughout the year will be used to defray the coStS 
of transportation and accomodations. 
